Your browser doesn't support javascript.
loading
Successful remission induction therapy with gilteritinib in a patient with de novo FLT3-mutated acute myeloid leukaemia and severe COVID-19.
Wilson, Andrew J; Troy-Barnes, Ethan; Subhan, Maryam; Clark, Fiona; Gupta, Rajeev; Fielding, Adele K; Kottaridis, Panagiotis; Mansour, Marc R; O'Nions, Jenny; Payne, Elspeth; Chavda, Naina; Baker, Robert; Thomson, Kirsty; Khwaja, Asim.
Afiliación
  • Wilson AJ; Department of Haematology, University College London Hospital (UCLH), London, UK.
  • Troy-Barnes E; UCLH Specialist Integrated Haematology Malignancy Diagnostic Service, Health Services Laboratories, London, UK.
  • Subhan M; Department of Haematology, University College London Hospital (UCLH), London, UK.
  • Clark F; Department of Haematology, University College London Hospital (UCLH), London, UK.
  • Gupta R; Department of Haematology, University College London Hospital (UCLH), London, UK.
  • Fielding AK; Department of Haematology, University College London Hospital (UCLH), London, UK.
  • Kottaridis P; Department of Haematology, University College London Cancer Institute, London, UK.
  • Mansour MR; UCLH Specialist Integrated Haematology Malignancy Diagnostic Service, Health Services Laboratories, London, UK.
  • O'Nions J; Department of Haematology, University College London Hospital (UCLH), London, UK.
  • Payne E; Department of Haematology, University College London Cancer Institute, London, UK.
  • Chavda N; Department of Haematology, University College London Hospital (UCLH), London, UK.
  • Baker R; Department of Haematology, University College London Hospital (UCLH), London, UK.
  • Thomson K; Department of Haematology, University College London Cancer Institute, London, UK.
  • Khwaja A; Department of Haematology, University College London Hospital (UCLH), London, UK.
Br J Haematol ; 190(4): e189-e191, 2020 08.
Article en En | MEDLINE | ID: mdl-32584418
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Pirazinas / Leucemia Mieloide Aguda / SARS-CoV-2 / Tratamiento Farmacológico de COVID-19 / Compuestos de Anilina Límite: Adult / Humans / Male Idioma: En Revista: Br J Haematol Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Pirazinas / Leucemia Mieloide Aguda / SARS-CoV-2 / Tratamiento Farmacológico de COVID-19 / Compuestos de Anilina Límite: Adult / Humans / Male Idioma: En Revista: Br J Haematol Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido